This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
FDA. Guidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA). Available at http://www.fda.gov/cber/gdlns/osteo.htm.
FDA. Guidance for industry: clinical development programs for drugs, devices, and biological products for the treatment of rheumatoid arthritis (RA). Available at http://www.fda.gov/cder/guidance/index.htm.
International Conference on Harmonization. Guidance on statistical principles for clinical trials. Available at http://www.fda.gov/cder/guidance/91698.pdf.
International Conference on Harmonization. Structure and content of clinical study reports. Available at http://www.fda.gov/cder/guidance/iche3.pdf.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Miller, C.G. (2008). Organization of the Clinical Trial by the Sponsor. In: Reid, D.M., Miller, C.G. (eds) Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-742-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-84628-742-8_8
Publisher Name: Springer, London
Print ISBN: 978-1-85233-874-9
Online ISBN: 978-1-84628-742-8
eBook Packages: MedicineMedicine (R0)